Enovis CORP (ENOV)

↓ Download CSV

CIK 0001420800 · NYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Enovis CORP reported revenue of $2.25B, up 6.7% from the prior year. The company ran a net loss, with a net margin of -52.7% and a gross margin of 59.8%. It held $3.83B in total assets against $2.34B in total liabilities.

Key ratios (FY2025)

59.8%
Gross margin
-50.0%
Operating margin
-52.7%
Net margin
-79.5%
Return on equity
+6.7%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$2.25B$2.11B$1.71B$1.56B$1.43B$1.12B$3.33B$2.19B$1.94B
Cost of Revenue$902.79M$926.87M$716.42M$693.72M$648.51M$517.06M$1.93B$1.46B$1.27B$2.19B
Gross Profit$1.35B$1.18B$990.78M$869.38M$777.67M$603.64M$1.40B$729.38M$671.58M$992.38M
Operating Income-$1.12B-$775.72M-$65.71M-$71.18M-$62.80M-$66.18M$203.61M$151.54M$135.60M$236.80M
Net Income-$1.18B-$825.49M-$33.26M-$13.29M$71.66M$42.62M-$527.65M$140.20M$151.09M$128.11M
EPS (Diluted)$-20.75$-14.93$-0.61$-0.25$1.40$0.93$-3.89$1.16$1.22$1.04
Total Assets$3.83B$4.72B$4.51B$4.27B$8.52B$7.35B$7.39B$6.62B$6.71B$6.34B
Total Liabilities$2.34B$2.15B$1.09B$823.45M$3.85B$3.76B$3.90B$3.14B$2.98B$3.25B
Shareholders' Equity$1.49B$2.56B$3.42B$3.45B$4.62B$3.54B$3.44B$3.27B$3.50B$2.90B
Cash & Equivalents$36.39M$48.17M$36.19M$24.30M$680.25M$97.07M$109.63M$77.15M$262.02M$208.81M
Operating Cash Flow$217.29M$113.50M$134.99M-$55.86M$356.10M$301.94M$130.95M$226.37M$218.77M$246.97M
Capital Expenditures$197.38M$180.71M$122.22M$105.45M$104.24M$114.78M$125.40M$69.65M$68.77M$63.25M
Shares Outstanding57.19M55.88M54.60M54.23M52.08M118.50M118.06M117.28M123.25M122.78M